Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**PRELID1 pseudogene 5 (PRELID1P5)** is classified as a pseudogene, which is a genomic DNA sequence similar to a gene but generally nonfunctional due to mutations such as frameshifts or premature stop codons[3][5]. PRELID1P5 is related to the parent gene PRELID1 (PRELI Domain Containing 1), which is involved in mitochondrial lipid transfer and is important for maintaining the mitochondrial membrane lipid cardiolipin, critical for mitochondrial function[1][2]. Pseudogenes like PRELID1P5 are not protein-coding and are typically not considered as therapeutic drug targets or direct participants in cellular function or disease. However, emerging research indicates that some pseudogenes may have regulatory functions or impact gene expression, though there is currently no evidence or annotation supporting a functional or disease-related role for PRELID1P5 specifically[5]. **Summary of key points:** - PRELID1P5 is a **pseudogene** and does not encode a functional protein[3][5]. - It is not classified as a therapeutic target (such as a receptor, enzyme, transporter, etc.). - It has no known biological function or disease association. - There are no interacting drugs, mechanisms of action, or biomarker roles reported. - Standard aliases include "PRELID1P5" and "PRELID1 Pseudogene 5"[3]. If you need information about the functional protein-coding gene PRELID1, which is related but distinct, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELID1 pseudogene 5 (PRELID1P5).